Latest Articles
- What does tumor shrinkage mean to the patient receiving chemotherapy?
Chemotherapy is often considered successful. if the tumor shrinks. But does tumor shrinkage alleviate symptoms and prolong life?
- Prevention of insulin-dependent diabetes mellitus: an overview of three trials
Clinicians are eagerly awaiting the results of three large-scale trials using different approaches to prevent IDDM.
- Preventive cardiology: Whose job is it? Who will pay for it? What is the best strategy?
Should cardiologists, internists, or nurse practitioners lead prevention efforts? What is the role of diet in the era of the statins?
- Interpreting serologic tests for hepatitis C virus infection: balancing cost and clarity
ELISA screening tests for HCV have unacceptably high false-positive rates. Newer tests are more accurate, but costly.
- Contemporary issues in cost-effective drug therapy
There is more to controlling pharmacy costs than choosing the least expensive drug. Preventing medication errors and reducing overall costs is key.
- Platelet transfusion therapy for medical and surgical patients
A discussion of the indications for platelet transfusions and factors that decrease their effectiveness.
- Benign prostatic hyperplasia: an approach for the internist
Paradoxically, the increase in treatment options for BPH is creating less certainty about which options to use. Some practical suggestions.
- Exercise and hypertension: common questions
Although for most patients with hypertension the benefits of exercise far outweigh the risks, surprisingly little data exists on this topic.
- Cardiac imaging techniques: which, when, and why
The science behind the different cardiac imaging techniques, and how to choose the best test for each patient.